Barbara R. Terlouw

Sep 11, 2023 | nature.com | Michael W. Mullowney |Somayah S. Elsayed |Neha Garg |Nathaniel Martin |David Meijer |Barbara R. Terlouw | +28 more

AbstractDevelopments in computational omics technologies have provided new means to access the hidden diversity of natural products, unearthing new potential for drug discovery. In parallel, artificial intelligence approaches such as machine learning have led to exciting developments in the computational drug design field, facilitating biological activity prediction and de novo drug design for molecular targets of interest.

Sep 11, 2023 | nature.com | Michael W. Mullowney |Somayah S. Elsayed |Neha Garg |Nathaniel Martin |David Meijer |Barbara R. Terlouw | +28 more

AbstractDevelopments in computational omics technologies have provided new means to access the hidden diversity of natural products, unearthing new potential for drug discovery. In parallel, artificial intelligence approaches such as machine learning have led to exciting developments in the computational drug design field, facilitating biological activity prediction and de novo drug design for molecular targets of interest.